mannitol has been researched along with Central Nervous System Neoplasm in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Ambady, P; Lin, P; Lujan, BJ; Neuwelt, EA; Simonett, JM; Skalet, AH | 1 |
Burks, SR; Frank, JA; Kersch, CN; Muldoon, LL; Neuwelt, EA; Pagel, MA; Sundby, M; Witko, JA | 1 |
Alahuhta, S; Isokangas, M; Keinänen, T; Kiviniemi, V; Korhonen, V; Kortelainen, J; Kuittinen, O; Myllylä, T; Nikkinen, J; Rytky, S; Siniluoto, T; Sonkajärvi, E; Tervonen, O; Tuovinen, T; Turpeenniemi-Hujanen, T; Voipio, J | 1 |
Alahuhta, S; Isokangas, M; Kuittinen, O; Peltonen, J; Siniluoto, T; Sonkajärvi, E; Turpeenniemi-Hujanen, T | 1 |
Cao, F; Lan, W; Li, D; Li, J; Li, L; Li, Y; Liu, X; Meng, R; Shi, C; Wang, H; Yang, B; Zhang, Y; Zhang, Z; Zhao, H; Zhou, J | 1 |
Fishburne, BC; Neuwelt, EA; Rosenbaum, JT; Wilson, DJ | 1 |
Apollo, D; Barnett, G; Janigro, D; Kapural, M; Krizanac-Bengez, Lj; Masaryk, T; Mayberg, MR; Perl, J; Rasmussen, P | 1 |
1 review(s) available for mannitol and Central Nervous System Neoplasm
Article | Year |
---|---|
[Chemotherapy in conjunction with blood brain barrier disruption in the treatment of primary central nervous system lymphoma].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Blood-Brain Barrier; Central Nervous System Neoplasms; Humans; Lymphoma; Mannitol | 2013 |
1 trial(s) available for mannitol and Central Nervous System Neoplasm
Article | Year |
---|---|
Arsenic trioxide and mannitol for the treatment of acute promyelocytic leukemia relapse in the central nervous system.
Topics: Adolescent; Adult; Arsenic Trioxide; Arsenicals; Blood-Brain Barrier; Central Nervous System Neoplasms; Child; Female; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Male; Mannitol; Middle Aged; Oxides; Recurrence; Remission Induction; Young Adult | 2014 |
5 other study(ies) available for mannitol and Central Nervous System Neoplasm
Article | Year |
---|---|
Risk Factors and Disease Course for Blood-Brain Barrier Disruption-Associated Maculopathy.
Topics: Adult; Antineoplastic Agents; Blood-Brain Barrier; Capillary Permeability; Central Nervous System Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Injections; Macular Degeneration; Male; Mannitol; Middle Aged; Osmosis; Retrospective Studies; Risk Assessment; Risk Factors | 2021 |
Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.
Topics: Animals; Blood-Brain Barrier; Carotid Arteries; Cell Adhesion; Cell Adhesion Molecules; Central Nervous System Neoplasms; Chemokines; Cytokines; Endothelial Cells; Humans; Immunity, Innate; Inflammation; Mannitol; Rats; Tight Junctions | 2021 |
Real-time monitoring of human blood-brain barrier disruption.
Topics: Adult; Aged; Anesthesia; Antineoplastic Agents; Blood-Brain Barrier; Capillary Permeability; Carotid Arteries; Central Nervous System Neoplasms; Electroencephalography; Female; Hemoglobins; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Mannitol; Middle Aged; Neurophysiological Monitoring; Oxyhemoglobins; Spectroscopy, Near-Infrared; Vertebral Artery; Young Adult | 2017 |
Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Blood-Brain Barrier; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Diuretics, Osmotic; Eye Neoplasms; Female; Humans; Injections; Lymphoma; Male; Mannitol; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Survival Rate; Visual Acuity; Vitreous Body | 1997 |
Serum S-100beta as a possible marker of blood-brain barrier disruption.
Topics: Biomarkers; Blood-Brain Barrier; Central Nervous System Neoplasms; Drug Administration Schedule; Humans; Infusions, Intra-Arterial; Lymphoma; Mannitol; Nerve Growth Factors; Phosphopyruvate Hydratase; Predictive Value of Tests; S100 Calcium Binding Protein beta Subunit; S100 Proteins | 2002 |